Aging Research and development
In June 2018, the World Health Organization (WHO) released the 11th edition of its International Classification of Diseases and added aging for the first time. The classification of aging as a disease paves the way for new research into novel therapeutics to
In this episode, Dr. Andrew Huberman is joined by Dr. David Sinclair, a tenured Professor of Genetics at Harvard Medical School and an expert researcher in longevity. Dr. Sinclair is also the author of Lifespan: Why We Age & Why
Highlights •NMN suppresses age-associated body weight gain and enhances energy metabolism •NMN improves insulin sensitivity, eye function, and other features with no toxicity •NMN prevents age-associated gene expression changes in a tissue-specific manner •NMN is an effective anti-aging intervention that
Rhonda delves into NAD+: its importance for aging, its decline as we age, and popular NAD+ enhancers like nicotinamide riboside and nicotinamide mononucleotide. NAD+ is vital for survival, with small dietary contributions, but the body mainly recycles it. Everyday life